Endocannabinoid signaling in microglial cells

Neuropharmacology

Volumn 56, Issue SUPPL. 1, 2009, Pages 244-253

  Stella, Nephi ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cannabinoid; Microglia; Neuroinflammation

Indexed keywords

CANNABINOID RECEPTOR; CANNABIS; DRONABINOL; ENDOCANNABINOID;

CANNABIS ADDICTION; HUMAN; MICROGLIA; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOCANNABINOIDS; MICROGLIA; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 58049170379     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.037     Document Type: Review

References (144)

1. Arévalo-Martín A., Vela J.M., Molina-Holgado E., Borrell J., and Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. The Journal of Neuroscience 23 (2003) 2511-2516
2. Baker D., Pryce G., Croxford L.J., Brown P., Pertwee R.G., Makriyannis A., Knanolkar A., Layward L., Fezza F., Bisogno T., and DiMarzo V. Endocannabinoids control spasticity in a multiple sclerosis model. The FASEB Journal 15 (2001) 300-302
3. Becher B., and Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18 (1996) 1-10
4. + current. The Journal of Biological Chemistry 278 (2003) 46188-46194
5. Beltramo M., and Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuropharmacology 11 (2000) 1231-1235
6. Benito C., Kim W.K., Chavarria I., Hillard C.J., Mackie K., Tolon R.M., Williams K., and Romero J. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. The Journal of Neuroscience 25 (2005) 2530-2536
7. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaques-associated glia in Alzheimer's disease brains. The Journal of Neuroscience 23 (2003) 11136-11141
8. 2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. The Journal of Neuroscience 27 (2007) 2396-2402
9. 1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. European Journal of Neuroscience 26 (2007) 3458-3464
10. Berger C., Schmid P.C., Schabitz W.R., Wolf M., Schwab S., and Schmid H.H. Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?. Journal of Neurochemistry 88 (2004) 1159-1167
11. Bilsland L.G., Dick J.R., Pryce G., Petrosino S., Di Marzo V., Baker D., and Greensmith L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. The FASEB Journal 20 (2006) 1003-1005
12. Blankman J.L., Simon G.M., and Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology 14 (2007) 1347-1356
13. 1. Biochemical Journal 312 (1995) 637-641
14. 2 peripheral cannabinoid receptor. European Journal of Biochemistry 237 (1996) 704-711
15. Breivogel C.S., Griffin G., Di Marzo V., and Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 60 (2001) 155-163
16. Caille S., Alvarez-Jaimes L., Polis I., Stouffer D.G., and Parsons L.H. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. The Journal of Neuroscience 27 (2007) 3695-3702
17. Campos A.C., and Guimaraes F.S. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berlin) 199 (2008) 223-230
18. 2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92 (1998) 3605-3615
19. 2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. International Immunopharmacology 2 (2002) 69-82
20. 2 receptor-dependent mechanism. Molecular Pharmacology 65 (2004) 999-1007
21. Chevaleyre V., Heifets B.D., Kaeser P.S., Sudhof T.C., and Castillo P.E. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron 54 (2007) 801-812
22. Costa B., Colleoni M., Conti S., Parolaro D., Franke C., Trovato A.E., and Giagnoni G. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn-Schmiedeberg's Archives of Pharmacology 369 (2004) 74-79
23. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., and De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 (2005) 1017-1021
24. Cravatt B.F., Saghatelian A., Hawkins E.G., Clement A.B., Bracey M.H., and Lichtman A.H. Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 10821-10826
25. Cravatt B.J., Demarest K., Patricelli M., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 9371-9376
26. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., and Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 8 (2005) 752-758
27. Davis M.I., Ronesi J., and Lovinger D.M. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. The Journal of Biological Chemistry 278 (2003) 48973-48980
28. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent C., Trzaskos J., Caboche J., and Girault J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. The Journal of Neuroscience 23 (2003) 2371-2382
29. 2 in the promyelocytic cells HL-60. The Journal of Biological Chemistry 275 (2000) 15621-15628
30. Derocq J.-M., Ségui M., Marchand J., Le Fur G., and Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Letters 369 (1995) 177-182
31. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
32. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Natural Reviews. Drug Discovery 7 (2008) 438-455
33. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
34. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., and Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 10819-10824
35. Dinh T.P., Kathuria S., and Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Molecular Pharmacology (2004)
36. Dirikoc S., Priola S.A., Marella M., Zsurger N., and Chabry J. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. The Journal of Neuroscience 27 (2007) 9537-9544
37. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., and Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006) 67-79
38. Facchinetti F., Del Giudice E., Furegato S., Passarotto M., and Leon A. Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia 41 (2003) 161-168
39. Fegley D., Gaetani S., Duranti A., Tontini A., Mor M., Tarzia G., and Piomelli D. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. The Journal of Pharmacology and Experimental Therapeutics 313 (2005) 352-358
40. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., and Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 7656-7660
41. 2 receptors. Molecular Pharmacology 48 (1995) 443-450
42. Ferrer B., Asbrock N., Kathuria S., Piomelli D., and Giuffrida A. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. European Journal of Neuroscience 18 (2003) 1607-1614
43. Fetler L., and Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science 309 (2005) 392-393
44. Franklin A., Parmentier-Batteur S., Walter L., Greenberg D.A., and Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cells motility. The Journal of Neuroscience 23 (2003) 7767-7775
45. 2 and abnormal-cannabidiol-sensitive receptors. European Journal of Pharmacology 474 (2003) 195-198
46. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry 232 (1995) 54-61
47. Garden G.A., and Moller T. Microglia biology in health and disease. Journal of Neuroimmune Pharmacology 1 (2006) 127-137
48. 2 receptor expression by TGF-β. Biochemical and Biophysical Research Communications 290 (2002) 91-96
49. Giuffrida A., Parsons L.H., Kerr T.M., Rodríguez de Fonseca F., Navarro M., and Piomelli D. Dopamine activation of endogenous cannabinoid signalling in dorsal striatum. Nature Neuroscience 2 (1999) 358-363
50. Glass M., and Northup J.K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Molecular Pharmacology 56 (1999) 1362-1369
51. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., and Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 18620-18625
52. 2 receptors: immunohistochemical localization in rat brain. Brain Research 1071 (2006) 10-23
53. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., and Hipkin R.W. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Molecular Pharmacology 57 (2000) 1045-1050
54. Goparaju K., Natsuo U., Yamaguchi H., and Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Letters 422 (1998) 69-73
55. Gordon S. Alternative activation of macrophages. Nature Reviews. Immunology 3 (2003) 23-35
56. Green D.R., and Beere H.M. Apoptosis. Gone but not forgotten. Nature 405 (2000) 28-29
57. 2 cannabinoid receptor. The Journal of Pharmacology and Experimental Therapeutics 292 (2000) 886-894
58. 2 receptor absence in the rat central nervous system. European Journal of Pharmacology 377 (1999) 117-125
59. Gulyas A.I., Cravatt B.F., Bracey M.H., Dinh T.P., Piomelli D., Boscia F., and Freund T.F. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. European Journal of Neuroscience 20 (2004) 441-458
60. Hájos N., and Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43 (2002) 503-510
61. Hájos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
62. Hansen H.H., Schmid P.C., Bittigau P., Lastres-Becker I., Berrendero F., Manzanares J., Ikonomidou C., Schmid H.H.O., and Fernández-RuizHansen H. Anandamide, but not 2-arachidonoylglycerol, accumulates during IN VIVO neurodegeneration. Journal of Neurochemistry 78 (2001) 1415-1427
63. Henry D.J., and Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neuroscience Letters 186 (1995) 91-94
64. Herring A.C., and Kaminski N.E. Cannabinol-mediated inhibition of nuclear factor-κB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes. The Journal of Pharmacology and Experimental Therapeutics 291 (1999) 1156-1163
65. Hoffman A.F., Macgill A.M., Smith D., Oz M., and Lupica C.R. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. European Journal of Neuroscience 22 (2005) 2387-2391
66. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., and Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 435 (2005) 1108-1112
67. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews 54 (2002) 161-202
68. l-selective cannabinoid receptor antagonist SR141716. Archives of General Psychiatry 58 (2001) 322-328
69. 2 receptors. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 14136-14141
70. Johns D.G., Behm D.J., Walker D.J., Ao Z., Shapland E.M., Daniels D.A., Riddick M., Dowell S., Staton P.C., Green P., Shabon U., Bao W., Aiyar N., Yue T.L., Brown A.J., Morrison A.D., and Douglas S.A. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. British Journal of Pharmacology 152 (2007) 825-831
71. Jordà M.A., Verbakel S.E., Valk P.J.M., Vankan-Berkhoudt Y.V., Maccarrone M., Finazzi-Agrò A., Löwenberg B., and Delwel R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99 (2002) 2786-2793
72. Karlsson M., Contreras J.A., Hellman U., Tornqvist H., and Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. Journal of Biological Chemistry 272 (1997) 27218-27223
73. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., and Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine 9 (2003) 76-81
74. 1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. The Journal of Neuroscience 26 (2006) 2991-3001
75. Khaspekov L.G., Brenz Verca M.S., Frumkina L.E., Hermann H., Marsicano G., and Lutz B. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. European Journal of Neuroscience 19 (2004) 1691-1698
76. 2 receptor. British Journal of Pharmacology 139 (2003) 775-786
77. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., and Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. The Journal of Cell Biology 137 (1997) 481-492
78. Kozak K.R., Rowlinson S.W., and Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. Journal of Biological Chemistry 275 (2000) 33744-33749
79. Lastres-Becker I., de Miguel R., De Petrocellis L., Makriyannis A., Di Marzo V., and Fernandez-Ruiz J. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. Journal of Neurochemistry 84 (2003) 1097-1109
80. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proceedings of the National Academy of Sciences of the United States of America 105 (2008) 2699-2704
81. 2 receptor mRNA in mouse immune cell subpopulation and following B cell stimulation. European Journal of Pharmacology 423 (2001) 235-241
82. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agro A., Cravatt B.F., and Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience 11 (2008) 152-159
83. Mackie K., and Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 3825-3829
84. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptors. The Journal of Neuroscience 15 (1995) 6552-6561
85. Makara J.K., Mor M., Fegley D., Szabo S.I., Kathuria S., Astarita G., Duranti A., Tontini A., Tarzia G., Rivara S., Freund T.F., and Piomelli D. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nature Neuroscience 8 (2005) 1139-1141
86. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., and Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 9561-9566
87. Maresz K., Carrier E.J., Ponomarev E.D., Hillard C.J., and Dittel B.N. Modulation of the cannabinoid CB receptor in microglial cells in response to inflammatory stimuli. Journal of Neurochemistry (2005)
88. 1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
89. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
90. 2 receptor participation. The Journal of Pharmacology and Experimental Therapeutics 289 (1999) 1620-1625
91. McKinney M.K., and Cravatt B.F. Structure and function of fatty acid amide hydrolase. Annual Review of Biochemistry 74 (2005) 411-432
92. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 50 (1995) 83-90
93. Mentlein R., Suttorp M., and Heymann E. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Archives of Biochemistry and Biophysics 228 (1984) 230-246
94. Molina-Holgado E., Vela J.M., Arévalo-Martin A., Almazán G., Molina-Holgado F., Borrell J., and Guaza C. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptor and phosphatidyllinositol-3 kinase/Akt signaling. The Journal of Neuroscience 22 (2002) 9742-9753
95. Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schutz G., Wotjak C.T., Lutz B., and Marsicano G. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biology 5 (2007) e269
96. Monory K., Tzavara E.T., Lexime J., Ledent C., Parmentier M., Borsodi A., and Hanoune J. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochemical and Biophysical Research Communications 292 (2002) 231-235
97. Muccioli G.G., and Stella N. An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. Analytical Biochemistry (2007)
98. Muccioli G.G., and Stella N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 54 (2008) 16-22
99. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
100. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005) 1314-1318
101. Nomura D.K., Blankman J.L., Simon G.M., Fujioka K., Issa R.S., Ward A.M., Cravatt B.F., and Casida J.E. Activation of the endocannabinoid system by organophosphorus nerve agents. Nature Chemical Biology (2008)
102. 2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53 (2004) 208-213
103. Offertáler L., Mo F., Bátkai S., Liu J., Begg M., Razdan R.K., Martin B.R., Bukoski R.D., and Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Molecular Pharmacology 63 (2003) 699-705
104. Oka S., Nakajima K., Yamashita A., Kishimoto S., and Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochemical and Biophysical Research Communications 362 (2007) 928-934
105. 2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS ONE 3 (2008) e1640
106. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., and Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413 (2001) 527-531
107. 9-tetrahydrocannabinol, cannabinol, and cannabidiol. Experientia (Basel) 29 (1973) 1368-1369
108. Peterson P.K., Gekker G., Hu S., Cabral G., and Lokensgard J.R. Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. Journal of Neuroimmunology 147 (2004) 123-126
109. Puffenbarger R.A., Boothe A.C., and Cabral G.A. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29 (2000) 58-69
110. Raivich G. Like cops on the beat: the active role of resting microglia. Trends in Neurosciences 28 (2005) 571-573
111. Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., and de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. The Journal of Neuroscience 25 (2005) 1904-1913
112. Rock R.B., Gekker G., Hu S., Sheng W.S., Cabral G.A., Martin B.R., and Peterson P.K. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. Journal of Neuroimmune Pharmacology 2 (2007) 178-183
113. 1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus. The Journal of Neuroscience 21 (2001) 823-833
114. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., and Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 152 (2007) 1092-1101
115. Schäbitz W.-R., Giuffrida A., Berger C., Aschoff A., Schwaninger M., Schwab S., and Piomelli D. Release of fatty acid amides in a patient with hemispheric stroke. Stroke 33 (2002) 2112-2114
116. 2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicology and Applied Pharmacology 142 (1997) 278-287
117. 2 peripheral cannabinoid receptor. Biochimica et Biophysica Acta 1307 (1996) 132-136
118. 1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies. Journal of Neuroimmunology 82 (1998) 13-21
119. Somma-Delpéro C., Valette A., Lepetit-Thévenin J., Nobili O., Boyer J., and Vérine A. Purification and properties of a monoacylglycerol lipase in human erythrocytes. Biochemical Journal 312 (1995) 519-525
120. Stefano G.B., Liu Y., and Goligorsky M.S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. The Journal of Biological Chemistry 271 (1996) 19238-19242
121. Stella N. Cannabinoid signaling in glial cells. Glia 48 (2004) 267-277
122. Stella N., and Piomelli D. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. European Journal of Pharmacology 425 (2001) 189-196
123. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
124. Streit W.J. Microglia and macrophages in the developing CNS. Neurotoxicology 22 (2001) 619-624
125. 2 receptor. The Journal of Biological Chemistry 275 (2000) 605-612
126. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 215 (1995) 89-97
127. Tornqvist H., and Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. The Journal of Biological Chemistry 251 (1976) 813-819
128. Trapp B.D., Wujek J.R., Criste G.A., Jalabi W., Yin X., Kidd G.J., Stohlman S., and Ransohoff R. Evidence for synaptic stripping by cortical microglia. Glia 55 (2007) 360-368
129. 1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
130. Turner C.E., Elsohly M.A., and Boeren E.G. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. Journal of Natural Products 43 (1980) 169-234
131. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., and Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. The Journal of Neuroscience 27 (2007) 3663-3676
132. 2 receptors. Science 310 (2005) 329-332
133. Vogel Z., Barg J., Levy R., Saya D., Heldman E., and Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with the cannabinoid receptors and inhibits adenylate cyclase. Journal of Neurochemistry 61 (1993) 352-355
134. 1) mediates inhibition of nitric oxide production by rat microglial cells. The Journal of Pharmacology and Experimental Therapeutics 288 (1999) 1357-1366
135. 1-receptor-triggered repression. Journal of Cell Science 121 (2008) 1704-1717
136. Walker J.M., Huang S.M., Strangman N.M., Tsou K., and Sañudo-Peña M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 12198-12203
137. Walter L., Franklin A., Witting A., Möller T., and Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. The Journal of Biological Chemistry 277 (2002) 20869-20876
138. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., and Stella N. Non-psychotropic cannabinoid receptors regulate microglial cell migration. The Journal of Neuroscience 23 (2003) 1398-1405
139. Witting A., Chen L., Cudaback E., Straiker A., Walter L., Rickman B., Moller T., Brosnan C., and Stella N. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 6362-6367
140. Witting A., Walter L., Wacker J., Moller T., and Stella N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 3214-3219
141. Witting A., Weydt P., Hong S., Kliot M., Moller T., and Stella N. Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice. Journal of Neurochemistry 89 (2004) 1555-1557
142. Wu L.J., and Zhuo M. Resting microglial motility is independent of synaptic plasticity in Mammalian brain. Journal of Neurophysiology 99 (2008) 2026-2032
143. 2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurology 6 (2006) 12
144. 2 receptors expression in the rat spinal cord of neuropathic but not inflammatory chronic pain model. European Journal of Neuroscience 17 (2003) 2750-2754